⌘K
Loading ticker…
Monopar Therapeutics Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Monopar Therapeutics Inc. Common Stock (MNPR) has a 3-month relative strength percentile of 92 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 71. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 2.18×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 92, Market Stance is mixed at 47, A/D rating B
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
MNPR is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $9M notional. Top 3 carry $18M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $9M |
| IWMiShares Russell 2000 ETF | 0.01% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.02% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MNPR Jan avg: 35.47% median: 24.84% win: 50% σ: 50.26% n: 4 2022-04-12 → 2026-05-29 | MNPR Feb avg: 26.37% median: -10.90% win: 25% σ: 80.81% n: 4 2022-04-12 → 2026-05-29 | MNPR Mar avg: -17.47% median: -8.99% win: 25% σ: 27.12% n: 4 2022-04-12 → 2026-05-29 | MNPR Apr avg: -4.03% median: -4.82% win: 20% σ: 12.25% n: 5 2022-04-12 → 2026-05-29 | MNPR May avg: -5.21% median: -7.42% win: 20% σ: 18.17% n: 5 2022-04-12 → 2026-05-29 | MNPR Jun avg: 6.78% median: 10.12% win: 75% σ: 13.81% n: 4 2022-04-12 → 2026-05-29 (current) | MNPR Jul avg: -4.29% median: -8.73% win: 25% σ: 13.75% n: 4 2022-04-12 → 2026-05-29 | MNPR Aug avg: -17.44% median: -14.95% win: 0% σ: 10.18% n: 4 2022-04-12 → 2026-05-29 | MNPR Sep avg: 75.39% median: 67.55% win: 50% σ: 100.02% n: 4 2022-04-12 → 2026-05-29 | MNPR Oct avg: 38.22% median: 33.67% win: 75% σ: 64.41% n: 4 2022-04-12 → 2026-05-29 | MNPR Nov avg: 6.65% median: 2.25% win: 75% σ: 35.99% n: 4 2022-04-12 → 2026-05-29 | MNPR Dec avg: -4.27% median: -5.07% win: 25% σ: 17.11% n: 4 2022-04-12 → 2026-05-29 |